Dr. Elise Riley is an Associate Professor in the Department of Medicine at the University of California, San Francisco. Trained as an epidemiologist, she has co-mentored 17 junior investigators and developed a longstanding multidisciplinary research program focused on HIV, drug use, health status and the use of health services in very low-income populations. She is currently funded by NIDA to conduct a homeless women's health study regarding the influences of HIV and polydrug use on cardiac injury. Here she proposes an expansion of the parent study to include two new biomarker outcomes, which will provide a better understanding of cardiac dysfunction through the consideration of multiple physiological pathways. Within this expanded body of research, Dr. Riley further proposes the concurrent augmentation of her mentoring activities for early career clinicians and trainees. The proposed activities leverage existing infrastructure, data and collaborations provided by Dr. Riley's current program, as well as additional NIH and UCSF resources. Collectively they will provide multiple opportunities for career development, a strong mentoring program for patient-oriented researchers and new projects that focus on understanding co-occurring exposures and health conditions to better inform health care delivery in highly vulnerable populations.
Poor health status and premature death among homeless women is due to a variety of complex and overlapping factors. A current NIDA-funded study led by Dr. Riley considers how combinations of drugs and medications exacerbate cardiac injury and poor health. The objective of the current proposal is to expand the existing research to consider additional physiological pathways of cardiac dysfunction, and augment mentoring activities alongside the research. This comprehensive program will provide an effective training environment for mentees conducting patient-oriented research. At the same time, it will facilitate the development of clinical tools for risk assessment to reduce cardiac dysfunction and poor health among homeless women.
|Christopoulos, Katerina A; Riley, Elise D; Carrico, Adam W et al. (2018) A Randomized Controlled Trial of a Text Messaging Intervention to Promote Virologic Suppression and Retention in Care in an Urban Safety-Net Human Immunodeficiency Virus Clinic: The Connect4Care Trial. Clin Infect Dis 67:751-759|
|Meacham, Meredith C; Bahorik, Amber L; Shumway, Martha et al. (2018) Condomless Sex and Psychiatric Comorbidity in the Context of Constrained Survival Choices: A Longitudinal Study Among Homeless and Unstably Housed Women. AIDS Behav :|
|Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115|
|Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771|
|Meacham, Meredith C; Ramo, Danielle E; Kral, Alex H et al. (2018) Associations between medical cannabis and other drug use among unstably housed women. Int J Drug Policy 52:45-51|
|Kim, Jin E; Flentje, Annesa; Tsoh, Janice Y et al. (2017) Cigarette Smoking among Women Who Are Homeless or Unstably Housed: Examining the Role of Food Insecurity. J Urban Health 94:514-524|
|Young, Dmitri A; Shumway, Martha; Flentje, Annesa et al. (2017) The relationship between childhood abuse and violent victimization in homeless and marginally housed women: The role of dissociation as a potential mediator. Psychol Trauma 9:613-621|
|Page, Kimberly; Yu, Michelle; Cohen, Jennifer et al. (2017) HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California. BMC Public Health 17:171|
|Brown, Rebecca T; Hemati, Kaveh; Riley, Elise D et al. (2017) Geriatric Conditions in a Population-Based Sample of Older Homeless Adults. Gerontologist 57:757-766|
|Riley, Elise D; Hsue, Priscilla Y; Vittinghoff, Eric et al. (2017) Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease. Drug Alcohol Depend 172:88-93|
Showing the most recent 10 out of 20 publications